MICROCHIP TECHNOLOGY ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2027

MICROCHIP TECHNOLOGY INC (MCHP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 NEWS RELEASE INVESTOR RELATIONS CONTACT: Sajid Daudi -- Head of Investor Relations..... (480) 792-7385 MICROCHIP TECHNOLOGY ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2027 • Net sales of $1.622 billion, increased 42.2% from the year-ago quarter and

Original reporting
Published Nov 5, 2026, 9:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MCHP
Bullish
high confidence
Mentioned
$MCHP
Relevance
9/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MCHPBullishHigh
01

Why it matters

The earnings beat and dividend raise are likely to drive short‑term buying, while the guidance for the upcoming quarter remains modestly positive.

02

Market read

First‑report earnings with strong growth and dividend boost make the news highly relevant for traders.

03

What to watch

Seasonality could cause a modest sequential dip in the December quarter despite the strong Q2.

Relevance 9/10Novelty 9/10Timing: immediate market reaction
AlphAI · Earnings readMCHP · second quarter of fiscal 2027 · ended September 30, 2026

Microchip reported second-quarter fiscal 2027 net sales of $1.622 billion, up 42.2% year over year and 9.2% sequentially, with GAAP diluted EPS of $0.68 and non-GAAP diluted EPS of $0.97.

✓Strong quarter

Net sales exceeded the August 6, 2026 guidance midpoint, year-over-year growth was 42.2%, profitability expanded substantially from the prior-year quarter, and operating cash flow and free cash flow increased sharply. December-quarter guidance calls for modest sequential revenue movement following $53 million of infrequent September-quarter revenue items.

Revenue
$1.62B
42.2% y/y · 9.2% q/q
Third Quarter Fiscal Year 2027 outlook
$1.573 to $1.638 billion
GM GAAP 62.9% to 63.9%; Non-GAAP 64.0% to 65.0%

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q2 fiscal 2027 net salesGAAP$1.62B9.2%42.2%
Q2 fiscal 2027 gross profitGAAP$1.07B––
Q2 fiscal 2027 gross profit percentageGAAP65.9%––
Q2 fiscal 2027 gross profitnon-GAAP$1.08B––
Q2 fiscal 2027 gross profit percentagenon-GAAP66.5%––
Q2 fiscal 2027 research and development expensesGAAP$318.5M––
Q2 fiscal 2027 research and development expensesnon-GAAP$274.5M––
Q2 fiscal 2027 selling, general and administrative expensesGAAP$186.9M––
Q2 fiscal 2027 selling, general and administrative expensesnon-GAAP$163.4M––
Q2 fiscal 2027 amortization of acquired intangible assetsGAAP$90.2M––
Q2 fiscal 2027 special charges and other, netGAAP$7.9M––
Q2 fiscal 2027 operating expensesGAAP$603.5M––
Q2 fiscal 2027 operating expensesnon-GAAP$437.9M––
Q2 fiscal 2027 operating incomeGAAP$464.5M––
Q2 fiscal 2027 operating income marginGAAP28.6%––
Q2 fiscal 2027 operating incomenon-GAAP$639.9M––
Q2 fiscal 2027 operating income marginnon-GAAP39.5%––
Q2 fiscal 2027 other expense, netGAAP−$47M––
Q2 fiscal 2027 income tax provisionGAAP$16.1M––
Q2 fiscal 2027 income tax rateGAAP3.9%––
Q2 fiscal 2027 income tax provisionnon-GAAP$33.7M––
Q2 fiscal 2027 income tax ratenon-GAAP5.7%––
Q2 fiscal 2027 net incomeGAAP$401.4M––
Q2 fiscal 2027 net income attributable to common stockholdersGAAP$373.6M––
Q2 fiscal 2027 net incomenon-GAAP$559.2M––
Q2 fiscal 2027 diluted net income per common shareGAAP$0.68––
Q2 fiscal 2027 diluted net income per common sharenon-GAAP$0.97––
Q2 fiscal 2027 diluted common shares outstandingGAAP550.6M––
Q2 fiscal 2027 diluted common shares outstandingnon-GAAP574.4M––
Q2 fiscal 2027 cash flow from operationsGAAP$419.2M––
Q2 fiscal 2027 capital expendituresGAAP−$23.1M––
Q2 fiscal 2027 free cash flowother$396.1M––
Six months ended September 30, 2026 net salesGAAP$3.11B––
Six months ended September 30, 2026 operating incomeGAAP$801.3M––
Six months ended September 30, 2026 net income attributable to common stockholdersGAAP$575.6M––
Six months ended September 30, 2026 non-GAAP net incomenon-GAAP$997.8M––
Six months ended September 30, 2026 diluted net income per common shareGAAP$1.05––
Six months ended September 30, 2026 non-GAAP diluted net income per common sharenon-GAAP$1.74––
Six months ended September 30, 2026 cash flow from operationsGAAP$930.7M––
Six months ended September 30, 2026 free cash flowother$893.7M––

Third Quarter Fiscal Year 2027 outlook

  • Revenue$1.573 to $1.638 billion
  • Gross marginGAAP 62.9% to 63.9%; Non-GAAP 64.0% to 65.0%
  • Operating expensesGAAP 36.7% to 37.4%; Non-GAAP 26.5% to 27.0%
  • NoteGAAP operating income: 25.5% to 27.2%; Non-GAAP operating income: 37.0% to 38.5%.
  • NoteGAAP other expense, net: $47.7 to $48.3 million; Non-GAAP other expense, net: $47.5 to $48.5 million.
  • NoteGAAP income tax provision: $67.1 to $91.3 million; Non-GAAP income tax provision: $34.7 to $37.9 million.
  • NoteGAAP net income: $285.9 to $305.8 million; Non-GAAP net income: $498.8 to $545.1 million.
  • NoteGAAP net income attributable to common stockholders: $258.1 to $278.0 million; Non-GAAP net income attributable to common stockholders: $498.8 to $545.1 million.
  • NoteGAAP diluted net income per common share: $0.47 to $0.50; Non-GAAP diluted net income per common share: $0.87 to $0.95.
  • NoteGAAP diluted common shares outstanding: Approximately 551.0 to 552.0 million shares; Non-GAAP diluted common shares outstanding: Approximately 574.8 to 575.8 million shares.
  • NoteCapital expenditures for the quarter ending December 31, 2026 are expected to be about $35 million.
  • NoteCapital expenditures for all of fiscal 2027 are expected to be approximately $100 million.
  • NoteNet sales are expected to be between down 3% and up 1% sequentially, with a midpoint of down 1%.
  • NoteThe midpoint of December-quarter guidance represents year-over-year growth of approximately 35.4%.

Capital returns

  • Returned approximately $247.6 million to common stockholders in the September quarter through dividends.
  • Quarterly cash dividend on common stock of 45.5 cents per share, payable on December 8, 2026 to stockholders of record on November 23, 2026.
  • Quarterly cash dividend on the 7.50% Series A Mandatory Convertible Preferred Stock of $18.750 per share, which represents $0.9375 per depositary share, payable on December 15, 2026 to stockholders of record on December 1, 2026.

What drove it

  • Management cited broad-based growth across end markets, driven by industrial and data center applications.
  • PCIe Gen6 switch and retimer design wins grew to 24 to date from 12 at the end of the June quarter.
  • Management said bookings remained robust and book-to-bill was well above one.
  • Management cited product and technology introductions across data center, aerospace and defense, automotive and industrial applications.
  • Non-GAAP operating expenses grew well below net sales, according to the CFO.
  • Microchip completed the Hailo acquisition on September 17th and the Vorago Technologies acquisition on October 8th.

Concerns

  • Management expects normal seasonal factors in the December quarter.
  • September-quarter revenue included about $53 million of infrequent revenue items that do not repeat in the December quarter.
  • Guidance excludes potential GAAP gains or charges from the ongoing evaluation of restructuring activities, including the sale of the Fab 2 wafer fabrication facility in Tempe, Arizona.
  • GAAP operating-expense guidance excludes certain Special Charges and Other, net that may be incurred during the quarter ending December 31, 2026.
  • Lead times are lengthening across the supply chain, and the company is working to expand capacity and secure additional wafer allocation.
  • Inventories increased to $1,117.3 million from $1,035.4 million at March 31, 2026.

What to watch

  • December-quarter net sales within the $1.573 to $1.638 billion guidance range and the stated sequential range of down 3% to up 1%.
  • Gross-margin performance versus GAAP guidance of 62.9% to 63.9% and non-GAAP guidance of 64.0% to 65.0%.
  • Whether bookings and book-to-bill remain robust as lead times lengthen.
  • The pace of capacity expansion and wafer-allocation availability.
  • Integration and expected benefits from the Hailo and Vorago Technologies acquisitions.
  • Capital expenditures versus expected spending of about $35 million for the December 2026 quarter and approximately $100 million for fiscal 2027.

Balance sheet and cash flow

  • Cash and short-term investments were $457.0 million at September 30, 2026, compared with $240.3 million at March 31, 2026.
  • Inventories were $1,117.3 million at September 30, 2026, compared with $1,035.4 million at March 31, 2026.
  • Long-term debt was $5,517.2 million at September 30, 2026, compared with $5,496.4 million at March 31, 2026.
  • Stockholders' equity was $6,640.8 million at September 30, 2026, compared with $6,432.4 million at March 31, 2026.
  • Q2 fiscal 2027 GAAP cash flow from operations was $419.2 million and free cash flow was $396.1 million.
  • Six months ended September 30, 2026 GAAP cash flow from operations was $930.7 million and free cash flow was $893.7 million.

Analysis

Microchip delivered a strong second quarter of fiscal 2027. Net sales were $1,621.5 million, up 42.2% from $1,140.4 million in the prior-year quarter and up 9.2% sequentially. The company stated that the August 6, 2026 guidance midpoint was $1.604 billion. Management attributed the growth to broad-based end-market demand led by industrial and data center applications, while stating that bookings remained robust and book-to-bill was well above one.

Profitability improved materially from the prior-year period. GAAP gross profit percentage was 65.9%, compared with 55.9%, and GAAP operating income was $464.5 million, compared with $88.9 million. Non-GAAP gross profit percentage was 66.5%, compared with 56.7%, while non-GAAP operating income rose to $639.9 million from $277.2 million. The CFO said non-GAAP operating expenses grew well below net sales, supporting the higher profitability.

GAAP net income attributable to common stockholders was $373.6 million, or $0.68 per diluted share, compared with $13.9 million, or $0.03 per diluted share. Non-GAAP net income was $559.2 million, or $0.97 per diluted share, compared with $199.1 million, or $0.35 per diluted share. Cash generation also strengthened: operating cash flow was $419.2 million and free cash flow was $396.1 million, compared with $88.1 million and $51.6 million, respectively. Cash and short-term investments were $457.0 million, while long-term debt was $5,517.2 million at September 30, 2026.

Capital allocation included approximately $247.6 million returned to common stockholders through dividends and a declared common-stock quarterly dividend of 45.5 cents per share. The company also completed the Hailo and Vorago Technologies acquisitions. Management said its existing manufacturing footprint enables growth with modest incremental capital investment, and forecast capital expenditures of about $35 million for the December 2026 quarter and approximately $100 million for fiscal 2027.

For the third quarter of fiscal 2027, Microchip guided net sales to $1.573 to $1.638 billion, with GAAP gross profit of 62.9% to 63.9% and non-GAAP gross profit of 64.0% to 65.0%. Management expects net sales to range from down 3% to up 1% sequentially, with a midpoint of down 1%, and noted that about $53 million of infrequent revenue items in the September quarter will not repeat. Management nevertheless characterized the midpoint as approximately 35.4% year-over-year growth and 5% to 7% better than normal seasonality after considering the infrequent revenue items.

Management, verbatim

Our September quarter net sales were above the high end of our guidance, increasing 42.2% year over year and 9.2% sequentially to $1.622 billion.

Steve Sanghi, President and Chief Executive Officer

Bookings remained robust, with book-to-bill well above one, consistent with recent quarters.

Steve Sanghi, President and Chief Executive Officer

Our September quarter results reflect ongoing operational improvements, with non-GAAP operating expenses growing well below net sales and supporting higher profitability.

Eric Bjornholt, Corporate Senior Vice President and Chief Financial Officer

Not in the filing

stated, not guessed
  • Prior-quarter dollar values for reported Q2 metrics were not provided.
  • Financial revenue or profit disclosures by operating segment were not provided.
  • Share repurchase activity was not provided.
  • A previous outlook section was not provided; therefore, no comparison of actual results with prior guidance is included.
  • GAAP and non-GAAP tax-rate guidance for the third quarter of fiscal 2027 was not provided.
  • Debt maturities, interest expense, and net debt were not provided.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Microchip Technology filed an 8‑K reporting its Q2 FY2027 financial results, including a dividend declaration and recent acquisitions of Hailo and Vorago.

Company-level read

Ticker impact

$MCHPBullishHigh confidence
Context

Microchip Technology reported Q2 FY2027 net sales of $1.622 billion, up 42.2% YoY, and GAAP EPS of $0.68, exceeding its prior guidance.

Expected impact

likely upside as results exceed guidance

Evidence & confidence

Revenue and EPS both beat the high end of the company’s own outlook, and the dividend announcement adds further support for buying pressure.

Market effects

Boosts outlook for the broader semiconductor sector, especially data‑center and industrial segments.

Positive for US tech equities and Nasdaq‑listed chips.

Reinforces global demand trends for AI‑enabled edge and data‑center chips.

Counterpoint

If supply‑chain constraints tighten further, the near‑term sales growth may be unsustainable.

Key entities

  • Microchip Technology Inc.

    Semiconductor manufacturer reporting Q2 FY2027 results.

  • Steve Sanghi

    President and CEO of Microchip, quoted on results.

Every MCHP earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$MPWRHighAI 9/10

Reflecting on analog semiconductors stocks’ Q3 earnings: Monolithic Power Systems (NASDAQ:MPWR)

Monolithic Power Systems (MPWR) reported Q3 revenue of $1.20B, up 63.1% YoY, exceeding estimates by 3.4%. The company raised guidance and saw a 14.7% stock increase. Impinj (PI) reported $112.1M revenue, up 16.7% YoY, but its stock fell 3.5%. Microchip Technology (MCHP) reported $1.62B revenue, up 42.2% YoY, but missed guidance, causing a 6% stock decline. NXP Semiconductors (NXPI) reported $3.79B revenue, up 19.3% YoY, and Power Integrations (POWI) reported $125.5M revenue, up 5.5% YoY.

$AXONMed

Watch AXON, MCHP, CHTR, and More

Axon Enterprise (AXON) fell 18.18% to $313, a 52-week low, after reporting earnings and increasing its stake in Skydio. Investors reacted negatively to the investment and guidance. Microchip Technology (MCHP) dropped 10%, with earnings and revenue up but supply chain issues. Charter Communications (CHTR) reported weak Q3 results, with declining cash flow and customer losses.

$MCHPHighAI 8/10

MCHP Q3 CY2026 deep dive: data center design wins offset by cautious outlook and supply constraints

Microchip Technology reported Q3 CY2026 revenue of $1.62B, beating estimates, with 42.2% YoY growth. Adjusted EPS was $0.97, also beating estimates. Guidance for Q4 was below expectations. The company cited strong demand in data centers and industrial sectors but noted supply constraints and inventory management challenges. Recent acquisitions and supply chain issues were discussed, with CEO Steve Sanghi highlighting extended lead times and potential margin pressures.

$MCHPMedAI 8/10

Microchip Technology stock drops 10% after weak December guidance

Microchip Technology's stock fell 10% after it forecast December-quarter sales below expectations, despite beating Q3 estimates. The company cited supply chain delays and one-off revenue items. CEO Steve Sanghi noted a potential slowdown in the data center market. Peers Texas Instruments and NXP provided more positive outlooks. Analysts adjusted price targets downward. The stock trades at a discount to its 5-year average.

$MCHPMedAI 8/10

The Chip Shortage Is Back, and Microchip Says AI Customers Are Crowding Everyone Out

Microchip Technology reported September quarter sales of $1.622B, exceeding forecasts, but warned of chip shortages due to AI demand. Shares fell 22.55% over two days. CEO Steve Sanghi noted AI buyers are crowding out other customers. December guidance was lowered, with sales expected between $1.573B and $1.638B. Analysts cut price targets but remain above Friday's close of $58.35.